CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 465 enrolled
Drug / intervention
Behavioral Feedback and Economic Incentives: Arm 1 +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03045276
NCT03045276N/ACompleted

Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial

Children's Hospital of Philadelphia·interventional·Posted Feb 7, 2017·Updated Nov 9, 2023

In Brief

A clinical study evaluating Behavioral Feedback and Economic Incentives: Arm 1 and Behavioral Feedback and Economic Incentives: Arm 2 for Spina Bifida and Kidney Transplant. Completed, enrolled 465 participants across 6 sites.

Detailed Summary

The purpose of this study is to determine the effectiveness of behavioral feedback plus economic incentives to promote treatment adherence among a large diverse population of adolescents and young adults (AYA) with kidney transplant (KT) or spina bifida (SB).

Study Details

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 7, 2017
Enrollment StartJun 29, 2017
Primary CompletionApr 9, 2022
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 9.4 years ago

Interventions

Behavioral Feedback and Economic Incentives: Arm 1behavioral

The purpose of this study is to determine the effectiveness of behavioral feedback plus economic incentives to promote treatment adherence among a large diverse population of adolescents and young adults (AYA) with kidney transplants (KT) or spina bifida (SB). In Arm 1, participants will not receive personalized feedback, nor will they receive the "extra" incentive of $10 for meeting their adherence goal.

Behavioral Feedback and Economic Incentives: Arm 2behavioral

The purpose of this study is to determine the effectiveness of behavioral feedback plus economic incentives to promote treatment adherence among a large diverse population of adolescents and young adults (AYA) with kidney transplants (KT) or spina bifida (SB). In Arm 2, participants will receive personalized feedback, and an "extra" incentive of $10 for meeting their adherence goal.